New Treatments for AML Remain Elusive, But Researchers Are UndeterredLauren M. Green
today announced it would present research on promising treatments for blood, prostate and other cancers, as well as studies on germline testing for hereditary cancers and on reducing heart disease in childhood cancer survivors...
Thanks to recent advances in Acute Myeloid Leukemia (AML), treatments have shown to improve remission and cure rates.2,3What are the available Acute Myeloid Leukemia (AML) treatments?There are several approved treatments for Acute Myeloid Leukemia (AML). Here are some of them: ...
City of Hope announced it would present research on promising treatments for blood, prostate and other cancers, as well as studies on germline testing for hereditary cancers and on reducing heart disease in childhood cancer survivors,...
Additionally, it is important to investigate possible synergistic effects between the ceramide-Tamoxifen regimen and existing treatments for AML. Combining this novel approach with conventional chemotherapy, targeted therapies, or immunotherapies may enhance treatment efficacy and improve patient outcomes. ...
Natural killer cell engagers in cancer immunotherapy: next generation of immuno-oncology treatments. Eur. J. Immunol. 51, 1934–1942 (2021). Article CAS PubMed Google Scholar Myers, J. A. & Miller, J. S. Exploring the NK cell platform for cancer immunotherapy. Nat. Rev. Clin. Oncol. ...
Meanwhile, there are still a large number of patients without sensitive driven mutations who are not available for TKI treatments [36]. Therefore, it is particularly important to find new therapeutic targets for NSCLC patients with different driven mutations or with TKI resistance. In recent years,...
“With all of the tools available to us today, as clinicians, we are really relying on cross-trial comparisons and safety cross-trial comparisons to guide our treatments. So, if we come back to the clinical dilemma that we all face today— what do we do with that [patient wi...
“The Phase II clinical trial of Daewoong Pharmaceutical’s Bersiposocin represents an important step in developing treatments that address the shortcomings of existing anti fibrotic therapies.” An official from Daewoong Pharmaceutical me...
[79]; additionally, treatments incorporating docetaxel (DTX) as a standard anticancer agent have produced survival advantages for patients with castration-resistant PC. Nevertheless, individuals undergoing repeated chemotherapy often exhibit resistance. Ma et al. reported the upregulation of DANCR in DTX-...